SBIR/STTR Research Award

Universal Probe Reagents for Detection and Quantitation of RNA Splicing

Award identifier 5fe94cc6d0d9f781dc8a986cfde4d1266d969128cda7d24626a58f5dae430231Awarding agency Department of Energy

Award amount

$749,146

Program and phase

SBIR · Phase II

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Energy
Branch
Not reported
Recipient company
Callida Genomics Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
DE-FG02-06ER06-09
Topic code
05

Research abstract

The number of genes in the genome of higher organisms is relatively small; however, the protein complexity arising from these genes has been shown to be much higher. In part, this is due to alternative splice variants that are created during the processing of gene transcripts. The formation of gene splice variants has implications for human disease (for example, in cancer susceptibility) and also for medical diagnostics, drug development, and bioengineering. However, there are hundreds of thousands of exons for each higher organism, which imposes a technical problem of generating millions of exon-specific detection reagents. This project will advance gene splice variant detection and quantitation by utilizing a small library of a few thousand universal-probe reagents and universal-probe microarrays, sufficient to analyze any gene from any organism. In Phase I, efficient assay designs and analysis software were developed, and accurate exon detection was demonstrated on 11 genes. Accurate exon detection was also demonstrated on pools of 10 cDNA clones representing 10 distinct genes. Over 300 cDNA clones (~1Mb of DNA) from 6 human tissues were efficiently analyzed using this new splice variant analysis method. Phase II will develop fully functional prototypes and user-friendly protocols, and perform end-user-directed testing of: (1) pre-made probe pools for human genes; (2) on-demand probe pools for gene mixes and genes from other organisms; and (3) a universal set of labeled probe pools for multiplex detection of DNA clones or amplicons longer than 100 bp. The technical goal is to provide novel or improved chips, probe reagents, assay kits, and software, underlying all three products. Commercial Applications and other Benefits as described by the awardee: Pre-made or easy made-on-demand-labeled gene probe cocktails, combined with universal 6-mer microarrays, would have many research and diagnostic applications, including fundamental studies of gene expression control, organism development and evolution, understanding disease susceptibility and progression such as in cancer, drug development for gene expression control, and agricultural and industrial research. An additional benefit involves the isolation of rare and complex splice variants for protein expression, without an expensive long gene synthesis process

Technology keywords

Not reported

Agency intelligence

Department of Energy

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.